Asia Pacific Muscle Relaxant Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Route of Administration (Oral and Injectable), By Distribution Channel, By Country and Growth Forecast, 2023 - 2029

The Asia Pacific Muscle Relaxant Drugs Market would witness market growth of 5.0% CAGR during the forecast period (2023-2029).

For people with spasticity who also have trouble swallowing tablets, the quickly dissolving flavored granules provide an option. The medication can be given to the patient in three different ways: straight into their mouths with or without water, while drinking or eating, or through an enteral feeding tube.

One of the main factors contributing to the rise in muscular weakness and musculoskeletal illnesses is the rising sedentary lifestyle and declining levels of activity, which is anticipated to drive the need for muscle relaxants throughout the forecasted period. For instance, research from around the world indicates that many adolescents do not engage in adequate physical activity. Furthermore, more than half of the population in economically developed nations is inactive.

Many medical professionals, especially rheumatologists, pain specialists, general practitioners, and mental health care professionals, have dealt with patients who report widespread chronic pain (pain all over the body), which is connected to several other symptoms like poor sleep, fatigue, and depression. Today, fibromyalgia (FM) is a diagnosis for this complicated combination of symptoms.

Osteoarthritis is the second most prevalent rheumatologic condition and the most prevalent joint disease in India, where its prevalence ranges from 22 to 38%. OA is more prevalent in women than in males, but the prevalence dramatically increases with age. Approximately 45% of women over 65 have symptoms, while 70% of those over 65 have radiological evidence. OA of the knee is a leading cause of mobility impairment, especially in women. It was estimated that osteoarthritis was the tenth leading cause of nonfatal burden. Thus, the high number of osteoarthritis cases will surge the demand for muscle relaxant drugs to ease the pain from such diseases, thereby driving the market's growth in the region.

The China market dominated the Asia Pacific Muscle Relaxant Drugs Market by Country in 2022 thereby, achieving a market value of $371.8 Million by 2029. The Japan market is registering a CAGR of 4.4% during (2023 - 2029). Additionally, The India market would showcase a CAGR of 5.6% during (2023 - 2029).

Based on Drug Type, the market is segmented into Skeletal, Neuromuscular Blocking Agents and Facial Muscle Relaxant Drugs. Based on Route of Administration, the market is segmented into Oral and Injectable. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy and Online Pharmacies. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

Free Valuable Insights: The Worldwide Muscle Relaxant Drugs Market is Projected to reach USD 4.7 Billion by 2029, at a CAGR of 4.3%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Amneal Pharmaceuticals, Inc., Ipsen Pharma Biotech SAS, Merz Pharma GmbH & Co. KGaA, Mallinckrodt PLC, Teva Pharmaceuticals Industries Ltd., Eisai Co., Ltd., Endo International PLC, Vertical Pharmaceuticals, LLC, SteriMax Inc., and Metacel Pharmaceuticals, LLC.

Scope of the Study

Market Segments Covered in the Report:

By Drug Type

• Skeletal
• Neuromuscular Blocking Agents
• Facial Muscle Relaxant Drugs

By Route of Administration

• Oral
• Injectable

By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacies

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

• Amneal Pharmaceuticals, Inc.
• Ipsen Pharma Biotech SAS
• Merz Pharma GmbH & Co. KGaA
• Mallinckrodt PLC
• Teva Pharmaceuticals Industries Ltd.
• Eisai Co., Ltd.
• Endo International PLC
• Vertical Pharmaceuticals, LLC
• SteriMax Inc.
• Metacel Pharmaceuticals, LLC

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Muscle Relaxant Drugs Market, by Drug Type
1.4.2 Asia Pacific Muscle Relaxant Drugs Market, by Route of Administration
1.4.3 Asia Pacific Muscle Relaxant Drugs Market, by Distribution Channel
1.4.4 Asia Pacific Muscle Relaxant Drugs Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Asia Pacific Muscle Relaxant Drugs Market by Drug Type
3.1 Asia Pacific Skeletal Market by Country
3.2 Asia Pacific Neuromuscular Blocking Agents Market by Country
3.3 Asia Pacific Facial Muscle Relaxant Drugs Market by Country

Chapter 4. Asia Pacific Muscle Relaxant Drugs Market by Route of Administration
4.1 Asia Pacific Oral Market by Country
4.2 Asia Pacific Injectable Market by Country

Chapter 5. Asia Pacific Muscle Relaxant Drugs Market by Distribution Channel
5.1 Asia Pacific Hospital Pharmacy Market by Country
5.2 Asia Pacific Retail Pharmacy Market by Country
5.3 Asia Pacific Online Pharmacies Market by Country

Chapter 6. Asia Pacific Muscle Relaxant Drugs Market by Country
6.1 China Muscle Relaxant Drugs Market
6.1.1 China Muscle Relaxant Drugs Market by Drug Type
6.1.2 China Muscle Relaxant Drugs Market by Route of Administration
6.1.3 China Muscle Relaxant Drugs Market by Distribution Channel
6.2 Japan Muscle Relaxant Drugs Market
6.2.1 Japan Muscle Relaxant Drugs Market by Drug Type
6.2.2 Japan Muscle Relaxant Drugs Market by Route of Administration
6.2.3 Japan Muscle Relaxant Drugs Market by Distribution Channel
6.3 India Muscle Relaxant Drugs Market
6.3.1 India Muscle Relaxant Drugs Market by Drug Type
6.3.2 India Muscle Relaxant Drugs Market by Route of Administration
6.3.3 India Muscle Relaxant Drugs Market by Distribution Channel
6.4 South Korea Muscle Relaxant Drugs Market
6.4.1 South Korea Muscle Relaxant Drugs Market by Drug Type
6.4.2 South Korea Muscle Relaxant Drugs Market by Route of Administration
6.4.3 South Korea Muscle Relaxant Drugs Market by Distribution Channel
6.5 Singapore Muscle Relaxant Drugs Market
6.5.1 Singapore Muscle Relaxant Drugs Market by Drug Type
6.5.2 Singapore Muscle Relaxant Drugs Market by Route of Administration
6.5.3 Singapore Muscle Relaxant Drugs Market by Distribution Channel
6.6 Malaysia Muscle Relaxant Drugs Market
6.6.1 Malaysia Muscle Relaxant Drugs Market by Drug Type
6.6.2 Malaysia Muscle Relaxant Drugs Market by Route of Administration
6.6.3 Malaysia Muscle Relaxant Drugs Market by Distribution Channel
6.7 Rest of Asia Pacific Muscle Relaxant Drugs Market
6.7.1 Rest of Asia Pacific Muscle Relaxant Drugs Market by Drug Type
6.7.2 Rest of Asia Pacific Muscle Relaxant Drugs Market by Route of Administration
6.7.3 Rest of Asia Pacific Muscle Relaxant Drugs Market by Distribution Channel

Chapter 7. Company Profiles
7.1 Amneal Pharmaceuticals, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Acquisition and Mergers:
7.2 Ipsen Pharma Biotech SAS
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Product Launches and Product Expansions:
7.3 Merz Pharma GmbH & Co. KGaA
7.3.1 Company Overview
7.4 Mallinckrodt PLC
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 Teva Pharmaceutical Industries Ltd.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expenses
7.6 Eisai Co., Ltd.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.7 Endo International PLC
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental Analysis
7.7.4 Research & Development Expense
7.8 Vertical Pharmaceuticals, LLC
7.8.1 Company Overview
7.9 SteriMax Inc.
7.9.1 Company Overview
7.10. Metacel Pharmaceuticals, LLC.
7.10.1 Company Overview

TABLE 1 Asia Pacific Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
TABLE 2 Asia Pacific Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
TABLE 3 Asia Pacific Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 4 Asia Pacific Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 5 Asia Pacific Skeletal Market by Country, 2019 - 2022, USD Million
TABLE 6 Asia Pacific Skeletal Market by Country, 2023 - 2029, USD Million
TABLE 7 Asia Pacific Neuromuscular Blocking Agents Market by Country, 2019 - 2022, USD Million
TABLE 8 Asia Pacific Neuromuscular Blocking Agents Market by Country, 2023 - 2029, USD Million
TABLE 9 Asia Pacific Facial Muscle Relaxant Drugs Market by Country, 2019 - 2022, USD Million
TABLE 10 Asia Pacific Facial Muscle Relaxant Drugs Market by Country, 2023 - 2029, USD Million
TABLE 11 Asia Pacific Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 12 Asia Pacific Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 13 Asia Pacific Oral Market by Country, 2019 - 2022, USD Million
TABLE 14 Asia Pacific Oral Market by Country, 2023 - 2029, USD Million
TABLE 15 Asia Pacific Injectable Market by Country, 2019 - 2022, USD Million
TABLE 16 Asia Pacific Injectable Market by Country, 2023 - 2029, USD Million
TABLE 17 Asia Pacific Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 18 Asia Pacific Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 19 Asia Pacific Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 20 Asia Pacific Hospital Pharmacy Market by Country, 2023 - 2029, USD Million
TABLE 21 Asia Pacific Retail Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 22 Asia Pacific Retail Pharmacy Market by Country, 2023 - 2029, USD Million
TABLE 23 Asia Pacific Online Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 24 Asia Pacific Online Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 25 Asia Pacific Muscle Relaxant Drugs Market by Country, 2019 - 2022, USD Million
TABLE 26 Asia Pacific Muscle Relaxant Drugs Market by Country, 2023 - 2029, USD Million
TABLE 27 China Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
TABLE 28 China Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
TABLE 29 China Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 30 China Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 31 China Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 32 China Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 33 China Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 34 China Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 35 Japan Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
TABLE 36 Japan Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
TABLE 37 Japan Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 38 Japan Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 39 Japan Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 40 Japan Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 41 Japan Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 42 Japan Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 43 India Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
TABLE 44 India Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
TABLE 45 India Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 46 India Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 47 India Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 48 India Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 49 India Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 50 India Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 51 South Korea Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
TABLE 52 South Korea Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
TABLE 53 South Korea Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 54 South Korea Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 55 South Korea Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 56 South Korea Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 57 South Korea Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 58 South Korea Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 59 Singapore Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
TABLE 60 Singapore Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
TABLE 61 Singapore Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 62 Singapore Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 63 Singapore Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 64 Singapore Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 65 Singapore Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 66 Singapore Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 67 Malaysia Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
TABLE 68 Malaysia Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
TABLE 69 Malaysia Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 70 Malaysia Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 71 Malaysia Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 72 Malaysia Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 73 Malaysia Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 74 Malaysia Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 75 Rest of Asia Pacific Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
TABLE 76 Rest of Asia Pacific Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
TABLE 77 Rest of Asia Pacific Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 78 Rest of Asia Pacific Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 79 Rest of Asia Pacific Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 80 Rest of Asia Pacific Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 81 Rest of Asia Pacific Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 82 Rest of Asia Pacific Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 83 Key Information – Amneal Pharmaceuticals, INc.
TABLE 84 Key Information – Ipsen Pharma Biotech SAS
TABLE 85 Key information – Merz Pharma GmbH & Co. KGaA
TABLE 86 Key information – Mallinckrodt PLC
TABLE 87 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 88 Key Information – Eisai Co., Ltd.
TABLE 89 Key Information – Endo International PLC
TABLE 90 Key Information – Vertical Pharmaceuticals, LLC
TABLE 91 Key Information – SteriMax Inc.
TABLE 92 Key Information – Metacel Pharmaceuticals, LLC.

List of Figures
FIG 1 Methodology for the research
FIG 2 Asia Pacific Muscle Relaxant Drugs Market Share by Drug Type, 2022
FIG 3 Asia Pacific Muscle Relaxant Drugs Market Share by Drug Type, 2029
FIG 4 Asia Pacific Muscle Relaxant Drugs Market by Drug Type, 2019 - 2029, USD Million
FIG 5 Asia Pacific Muscle Relaxant Drugs Market Share by Route of Administration, 2022
FIG 6 Asia Pacific Muscle Relaxant Drugs Market Share by Route of Administration, 2029
FIG 7 Asia Pacific Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2029, USD Million
FIG 8 Asia Pacific Muscle Relaxant Drugs Market Share by Distribution Channel, 2022
FIG 9 Asia Pacific Muscle Relaxant Drugs Market Share by Distribution Channel, 2029
FIG 10 Asia Pacific Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2029, USD Million
FIG 11 Asia Pacific Muscle Relaxant Drugs Market Share by Country, 2022
FIG 12 Asia Pacific Muscle Relaxant Drugs Market Share by Country, 2029
FIG 13 Asia Pacific Muscle Relaxant Drugs Market by Country, 2019 - 2029, USD Million